EC-18, a Synthetic Monoacetyldiacylglyceride, Inhibits Hematogenous Metastasis of KIGB-5 Biliary Cancer Cell in Hamster Model
Journal of Korean Medical Science
;
: 474-480, 2009.
Article
in English
| WPRIM
| ID: wpr-134346
ABSTRACT
EC-18 (monoacetyldiacylglyceride) stimulates T cell production of IL-2, IL-4, IL-12, IFN-gamma, and GM-CSF in vitro. To study the effects of these cytokines stimulated by EC-18 on cancer cells, we applied hamster biliary cancer model, a difficult cancer to treat. Cancer (KIGB-5) cells were given intravenously to produce hematogenous metastatic lung lesions which were treated with EC-18 at 10, 25, and 50 mg/kg/day respectively. The fourth group was untreated control. At 4th, 8th, and 12th week the lungs were examined. EC-18 treated groups showed only a few microscopic lung lesions and no evidence of metastatic lesion with highest dose whereas widespread gross lung lesions were observed in untreated control. To investigate whether the anti-tumor effect of EC-18 is associated with suppression of tumor cell Toll-like receptor 4 (TLR-4) expression in addition to stimulation of the immune cells, KIGB-5 cells were exposed to LPS with or without EC-18. TLR-4 mRNA and protein expression, measured by reverse transcriptase PCR (RT-PCR), real-time quantitative PCR and western blot analysis, showed suppression of TLR-4 expression in KIGB-5 cells treated with EC-18 compared with control. In conclusion, EC-18 has a significant anti-tumor effect in this experimental model of biliary cancer suggesting potential for clinical application to this difficult cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Biliary Tract Neoplasms
/
Tumor Cells, Cultured
/
T-Lymphocytes
/
Cytokines
/
Toll-Like Receptor 4
/
Glycerides
/
Lung
/
Neoplasm Metastasis
/
Antineoplastic Agents
Limits:
Animals
Language:
English
Journal:
Journal of Korean Medical Science
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS